A phase I study of the effects of hepatic impairment on the pharmacokinetics and safety of satraplatin in patients with refractory non-hematologic cancer
Phase of Trial: Phase I
Latest Information Update: 24 Jul 2006
At a glance
- Drugs Satraplatin (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 24 Jul 2006 New trial record.